Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective [0.03%]
从哥伦比亚医疗保健系统视角看治疗局部晚期或转移性尿路上皮癌新型一线疗法的治疗费用和预算影响
Pieralessandro Lasalvia,Paola Jaramillo,Maycos Zapata et al.
Pieralessandro Lasalvia et al.
Background: Locally advanced or metastatic urothelial carcinoma (la/mUC) imposes substantial clinical and economic burden. Novel first-line (1L) therapies have expanded treatment options but may significantly increase hea...
Burden Tree - a conceptual framework for the burden associated with pediatric infectious diseases: a Delphi approach [0.03%]
负担树——儿童传染病负担的概念框架：德尔菲法 접근
Cristina Carias,Danielle Riley,Amanda L Eiden et al.
Cristina Carias et al.
Background: Accurate economic evaluations require capturing the full value of health interventions, yet broader impacts are often inconsistently represented. This study developed and validated the 'Burden Tree'- a concept...
Knowledge, perception and application of pharmacoeconomics among healthcare professionals in Malaysia [0.03%]
马来西亚医疗专业人员的药物流行病学知识、认知和应用状况
Haarathi Chandriah,Ee Vien Low,Nur Sufiza Ahmad et al.
Haarathi Chandriah et al.
Background: Pharmacoeconomics (PE) is essential in optimizing healthcare resource allocation and ensuring cost-effective treatment decisions. Despite its recognized importance, limited evidence exists regarding healthcare...
Medication adherence research: expert perspectives on key HEOR trends for 2026 [0.03%]
依从性研究：专家视角下的关键HEOR趋势（至2026年）
Tamas Agh,Bijan Borah,Marcia Vervloet et al.
Tamas Agh et al.
Net benefits of investing in pulse oximetry and oxygen for childhood pneumonia in high burden countries [0.03%]
向肺炎高负担国家投资脉搏血氧仪和氧气的净效益分析
Tim Colbourn,Carina King
Tim Colbourn
Cost-effectiveness analysis of point-of-care A1C tests in the primary care setting of Iran [0.03%]
伊朗基层医疗环境中糖化血红蛋白检测的 cost-effectiveness 分析
Abdoreza Mousavi,Mehdi Raadabadi,Ali Darvishi
Abdoreza Mousavi
Background: Given the critical role of timely monitoring in diabetes management, effective and accessible testing strategies are increasingly vital. This study evaluated the cost-effectiveness of point-of-care A1c (POC-A1...
Physicians' preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China [0.03%]
中国医生在慢性丙型肝炎直接抗病毒治疗中的偏好的证据：来自中国的离散选择实验结果
Yan Li,Junni Du,Chenhui Tian et al.
Yan Li et al.
Background: Chronic hepatitis C (CHC) remains a major public health challenge in China. Currently, direct-acting antivirals (DAAs) are the mainstay of clinical treatment. This study employed a discrete choice experiment (...
Correction [0.03%]
改正
Duration changes and decision-making in DCETTO: evidence from SF-6Dv2 [0.03%]
DCETTO中持续时间变化与决策的证据：SF-6Dv2研究
Hosein Ameri,Thomas G Poder
Hosein Ameri
Background: This study investigated the impact of changes in health state duration in discrete choice experiment where duration is an attribute (DCETTO). ...
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer [0.03%]
曲妥珠单抗联合Tucatinib与曲妥珠单抗联合帕妥珠单抗治疗化疗耐药的RAS野生型HER2阳性不可切除或转移性结直肠癌的成本效益分析
Mengmeng Liu,Lu Zhong,Mei Dong et al.
Mengmeng Liu et al.
Background: This study evaluates the cost-effectiveness of tucatinib plus trastuzumab compared to pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal...